Trendlines Group

Trendlines Group specializes in strategic investments across the agrifood and medical technology sectors, guiding innovative startups through their entire development journey from initial concept to commercial success. With a comprehensive approach to venture capital, the firm provides not only financial backing but also leverages its extensive industry expertise, global partnership ecosystem, and specialized resources to transform promising seed-stage technologies into market-ready solutions. This hands-on investment methodology has positioned Trendlines as a respected player in the early-stage innovation landscape, particularly in sectors addressing global food security and healthcare challenges.

As a publicly traded entity, Trendlines offers investors unique access to early-stage innovation markets through its dual listing structure. The company's primary shares trade on the Singapore Stock Exchange under the ticker SGX: 42T, while American investors can access the company through American Depositary Receipts (ADRs) available on the OTCQX International platform under OTCQX: TRNLY. This international presence reflects the company's global approach to both sourcing investment opportunities and creating exit pathways for its portfolio companies.

The firm's investment portfolio encompasses a diverse range of companies developing solutions for critical global challenges. In agrifood technology, Trendlines backs innovations addressing sustainable farming, alternative proteins, food safety, and supply chain optimization. Their medtech investments span medical devices, digital health platforms, diagnostic technologies, and therapeutic innovations. This strategic diversification across complementary sectors allows Trendlines to capitalize on cross-industry synergies while maintaining focused expertise in each domain.

Beyond capital deployment, Trendlines operates a distinctive incubation model that includes business development support, R&D guidance, regulatory navigation assistance, and access to follow-on funding networks. The company has established innovation centers and partnership agreements with major corporations, research institutions, and government entities across multiple continents. This ecosystem approach enables portfolio companies to accelerate their development timelines, overcome common startup hurdles, and establish the commercial foundations necessary for sustainable growth and successful exits through strategic acquisitions or public offerings.